Collplant
-
Business
Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials
Regenerative medicine company and 3D bioprinter material developer Collplant (NASDAQ:CLGN) , has reported its financial results for the third quarter…
Read More »